CN103142978A

CN103142978A - Medicine for treating peripheral facial paralysis

Info

Publication number: CN103142978A
Application number: CN2013101111806A
Authority: CN
Inventors: 邓广博
Original assignee: Individual
Current assignee: Individual
Priority date: 2013-03-22
Filing date: 2013-03-22
Publication date: 2013-06-12

Abstract

The invention relates to a medicine for treating peripheral facial paralysis. The medicine is prepared from the following substances in percentage by weight: 5-10 parts of radix scrophulariae, 10-20 parts of dried ginger, 20-30 parts of dogwood, 10-20 parts of balloon flower, 15-25 parts of angelica dahurica, 5-15 parts of inula britannica chinensis, 10-30 parts of seed of cowherb, 1-15 parts of fibraurea recisa, 10-20 parts of radix sileris, 15-30 parts of Chinese ephedra, 20-30 parts of terminaliae billericae, 1-20 parts of morinda root, 10-20 parts of celandine, 10-25 parts of cogongrass rhizome, 10-30 parts of fructus xanthil, 1-20 parts of oil orange, 15-20 parts of murraya jasminorage, 10-20 parts of morning glory seed, 15-20 parts of Japanese inula herb, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of senna, 5-15 parts of aleppo avens, 1-20 parts of radix rhapontici, 15-25 parts of dahurian rhododendron leaf, 15-25 parts of cockscomb flower, 10-20 parts of physalis alkekengi, 15-25 parts of cortex mori radicis, 20-30 parts of myrrh, 1-20 parts of ligaloes and 10-25 parts of lily magnolia. All the components of the medicine for treating peripheral facial paralysis are natural materials. The medicine for treating peripheral facial paralysis has good security and definite curative effect and is suitable for large-scale popularization in clinical practice.

Description

A kind of medicament for the treatment of peripheral facial paralysis

Technical field

The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of peripheral facial paralysis.

Background technology

Peripheral facial paralysis refers to idiopathic facial palsy, claims again Bell's palsy, refers to one-sided infranuclear facial palsy agnogenio, acute onset.It is commonly encountered diseases.Any age all can fall ill, and the male is slightly many.Usually Acute onset, reach the peak within a few hours or 1～2 day.Sick just can have pain after angle of mandible or ear.Cardinal symptom is a side surface part histrionic muscles paralysis.The volume stricture of vagina disappears, can not frown, and the palpebral fissure dysraphism, when examination was closed one's eyes, the paralysis branch hole ball foreign side that makes progress rotated, and exposes white sclera, claims bell's phenomenon.Sick side nasolabial fold shoals, ptosis of labial angle, and is askew to strong side in the time of grinningly, because of orbicularis oris paralysis air-blowing or gas leakage when whistling, because the buccinator muscle food of paralysing easily is stranded between disease side tooth cheek.When pathological changes is above at tympanic cord scope of participants neural place, the homonymy gustatory anesthesia can be arranged.

Summary of the invention

The purpose of this invention is to provide a kind of medicament for the treatment of peripheral facial paralysis.

in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of peripheral facial paralysis, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Flos Celosiae Cristatae 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Myrrha 20-30 part, Lignum Aquilariae Resinatum 1-20 part and Flos Magnoliae 10-25 part.

preferably, the medicament for the treatment of peripheral facial paralysis of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Flos Celosiae Cristataes, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Myrrhas, 24 parts of 16 parts of Lignum Aquilariae Resinatum and Flos Magnoliaes.

More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.

Whole compositions of the medicament for the treatment of peripheral facial paralysis of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.

The specific embodiment

Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.

Embodiment decoction of the present invention

take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Ephedrae 24 grams, Fructus Terminaliae Billericae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Flos Celosiae Cristatae 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Myrrha 26 grams, Lignum Aquilariae Resinatum 16 grams and Flos Magnoliae 24 grams, add 2000 milliliters of entry, in being housed, heated 4 hours under 80 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.

Experimental example

Diagnostic criteria

Reference " neurological " (Wang Weizhi. neurological [M]. Beijing: People's Health Publisher, 2005:90.) work out: (1) onset is hurried, have before sick more suffer from cold, blowing or pharyngitis history, small number of patients after disease a few days ago can have ear, the symptom in earlier stage such as in ear pain or facial discomfort; (2) one side surface part muscle paralysis and numbness facial hemiparalysiss, palpebral fissure increase, hypophasis or can not be closed, volume stricture of vagina and nasolabial fold shoal or disappear, whole volume, frown, show tooth, drum cheek obstacle, gargle leak, when having meal between the residual tooth cheek of food; (3) front 2/3 hypogeusia of tongue or disappearance hyperacusis can appear in the part Ipsilateral, and ear's herpes can appear in minority.Get rid of the disease that cerebrovascular accident, otitis media, tumor, meningitis, surgical injury, Guillain Barre etc. cause facial paralysis.

Choose patient's 60 examples that meet above-mentioned standard, male 30 examples wherein, female's 30 examples; 25～45 years old age, average 32 years old.

Use the decoction for preparing in embodiment to treat, every day 2 times, each oral 50 milliliters, treating 7 days is a course for the treatment of.

Criterion of therapeutical effect

Reference " the tcm internal medicine disease treatment is conventional " criterion of therapeutical effect (the red legend cutting edge of a knife or a sword. national standard is used tcm internal medicine disease treatment conventional [M]. Changsha: Hunan science tech publishing house, 1993:266.) formulate.Recovery from illness: symptom disappears fully, and a mouthful eye is rectified, and nasolabial fold is symmetrical, frown, close order, grinningly rouse the cheek, pout one's lips etc. and to recover normal; Take a turn for the better: symptom and sign improves, but leaves over facial muscle dysfunction in various degree, has slightly asymmetricly as the outward appearance face, and catacleisis is not good enough, and during laugh, bicker is slightly crooked etc.; Invalid: symptom, sign are without improvement.

Through the treatment of a course for the treatment of, find that all patients' symptom disappears fully, a mouthful eye is rectified, nasolabial fold is symmetrical, frown, close order, grinningly rouse the cheek, pout one's lips etc. and to recover normal, all meet the standard of recovery from illness, and do not observe obvious untoward reaction during whole treatment.

Claims

1. medicament for the treatment of peripheral facial paralysis, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Flos Celosiae Cristatae 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Myrrha 20-30 part, Lignum Aquilariae Resinatum 1-20 part and Flos Magnoliae 10-25 part.

2. the medicament for the treatment of peripheral facial paralysis according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Flos Celosiae Cristataes, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Myrrhas, 24 parts of 16 parts of Lignum Aquilariae Resinatum and Flos Magnoliaes.

3. the medicament for the treatment of peripheral facial paralysis according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.